Repression of the CDK activator Cdc25A and cell-cycle arrest by cytokine TGF-β in cells lacking the CDK inhibitor p15

Nature

Volumn 387, Issue 6631, 1997, Pages 417-422

  Iavarone, Antonio ^a   Massagué, Joan ^a  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CANCER CELL CULTURE; CELL CYCLE; ENZYME INACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION;

CARRIER PROTEINS; CDC25 PHOSPHATASE; CELL CYCLE; CELL CYCLE PROTEINS; CELL LINE; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASE 6; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASES; CYCLINS; DOWN-REGULATION; ENZYME ACTIVATION; MUTAGENESIS; PHOSPHOPROTEIN PHOSPHATASE; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; RETINOBLASTOMA PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 0030978315     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/387417a0     Document Type: Article

References (30)

1. Sheer, C. J. & Roberts, J. M. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9, 1149-1163 (1995).
2. Morgan, D. O. Principles of CDK regulation. Nature 374, 131-134 (1995).
3. Harmon, G. J. & Beach, D. p15INK4B is a potential effector of TGFβ-induced cell-cycle arrest. Nature 371, 257-261 (1994).
4. Reynisdóttir, I., Polyak, K., Iavarone, A. & Massagué, J. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-β. Genes Dev. 9, 1831-1845 (1995).
5. Reynisdóttir, I. & Massagué, J. The subcellular locations of p15Ink4b and p27Kip1 coordinate their inhibitory interactions with cdk4 and cdk2. Genes Dev. 11, 492-503 (1997).
6. Kamb, A. et al. A cell cycle regulator potentially involved in genesis of many tumor types. Science 264, 436-440 (1994).
7. Nobori, T. et al. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 368, 753-756 (1994).
8. Soule, H. D. et al. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res. 50, 6075-6086 (1990).
9. Matsushime, H. et al. D-type cyclin-dependent kinase activity in mammalian cells. Mol. Cell. Biol. 14, 2066-2076 (1994).
10. Meyerson, M. & Harlow, E. Identification of G1 kinas activity for Cdk6, a novel cyclin D partner. Mol. Cell. Biol. 14, 2077-2086 (1994).
11. Schulze, A. et al. Cell cycle regulation of the cyclin A gene promoter is mediated by a variant E2F site. Proc. Natl Acad. Sci. USA 92, 11264-11268 (1995).
12. Fisher, R. P. & Morgan, D. O. A novel cyclin associates with MO15/CDK7 to form the CDK-activating kinase. Cell 78, 713-724 (1994).
13. Hoffmann, I., Draetta, G. & Karsenti, E. Activation of the phosphatase activity of human cdc25A by a cdk2-cyclin E dependent phosphorylation at trie G1/S transition. EMBO J. 13, 4302-4310 (1994).
14. Jinno, S. et al. Cdc25A is a novel phosphatase functioning early in the cell cycle. EMBO J. 13, 1549-1556 (1994).
15. Terada, Y., Tatsuka, M., Jinno, S. & Okayama, H. Requirement for tyrosine phosphorylation of Cdk4 in G1 arrest induced by ultraviolet irradiation. Nature 376, 358-362 (1995).
16. Meyerson, M. et al. A family of human cdc2-related protein kinases. EMBO J. 11, 2909-2917 (1992).
17. Pietenpol, J. A. et al. TGF-β1 Inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming protein with pRB binding domeins. Cell 61, 777-785 (1990).
18. Galaktionov, K., Chen, X & Beach, D. Cdc25 cell-cycle phosphatase as a target of c-Myc. Nature 382, 511-517 (1996).
19. Ewen, M. E., Sluss, H. K., Whitehouse, L. L. Livingston, O. M. TGF-β inhibition of Cdk4 synthesis is linked to cell cycle arrest. Cell 74, 1009-1020 (1993).
20. Polyak, K. et al. p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev. 8, 9-22 (1994).
21. Polyak, K. et al. Cloning of p27Kip1 a cyclin-cdk inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78, 59-66 (1994).
22. Galaktionov, K. et al. CDC25 phosphatases as potential human oncogenes. Science 269, 1575-1577 (1995).
23. Markowitz, S. et al. Inactivation of the type II TGFβ receptor in colon cancer cells with microsatellite instability. Science 268, 1336-1338 (1995).
24. Eppert, K. et al. MADR2 maps to 18q21 and encodes a TGFβ-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell 86, 543-552 (1996).
25. Hahn, S. A. et al. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 271, 350-353 (1996).
26. Giaretti, W. & Nuss, M. Light scatter of isolated cell nuclei as a parameter discriminating the cell-cycle subcompartment. Meth. Cell Biol. 41, 389-400 (1994).
27. van den Heuvel, S. & Harlow, E. Distinct role for cyclin-dependent kinases in cell cycle control. Science 262, 2050-2054 (1993).
28. Boukamp, P. et al. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J. Cell Biol. 106, 761-771 (1988).
29. Galaktionov, K. & Beach, D. Specific activation of cdc25 tyrosine phosphatases by B-type cyclins: evidence for mutliple roles of mitotic cyclins. Cell 67, 1181-1194 (1991).
30. Lukas, J., Bartokova, J., Rohde, M., Strauss, M. & Bartek, J. Cyclin D1 is dispensable for G1 control in retinoblastoma gene-deficient cells independently of cdk4 activity. Mol. Cell. Biol. 15, 2600-2611 (1995).